32976205|t|Intranasal dexmedetomidine versus oral midazolam premedication to prevent emergence delirium in children undergoing strabismus surgery: A randomised controlled trial.
32976205|a|BACKGROUND: Dexmedetomidine is being used increasingly as a premedicant in the paediatric population. However, the effectiveness of pre-operative intranasal dexmedetomidine premedication, compared with oral midazolam, for emergence delirium is not well characterised. OBJECTIVE: To identify the effectiveness of pre-operative intranasal dexmedetomidine for emergence delirium in the paediatric patient population following general anaesthesia. DESIGN: A prospective, randomised, double-blind, parallel-group, placebo-controlled trial. SETTING: Single university teaching hospital, from September 2013 to August 2014. PATIENTS: One hundred and fifty-six patients undergoing anaesthesia for strabismus surgery were included in the study. INTERVENTION: Patients were randomised in a 1 : 1 : 1 ratio to receive premedication with intranasal dexmedetomidine 2 mug kg (the dexmedetomidine group), oral midazolam 0.5 mg kg (the midazolam group), or 0.9% saline (the placebo group). MAIN OUTCOME MEASURES: The primary outcome was the incidence of emergence delirium assessed by the Paediatric Anaesthesia Emergence Delirium scale. Secondary outcomes included the quality of the inhalational induction, emergence time, postoperative pain intensity, length of stay in the postanaesthesia care unit, the incidence of postoperative nausea or vomiting (PONV) and parents' satisfaction. RESULTS: The incidence of emergence delirium was lower in patients given dexmedetomidine compared with that in patients given midazolam (11.5 versus 44%, relative risk = 0.262, 95% confidence interval 0.116 to 0.592) or 0.9% saline (11.5 versus 49%, relative risk = 0.235, 95% confidence interval 0.105 to 0.525). Likewise, the incidence of PONV was lower in the dexmedetomidine group (3.8%) than that in the midazolam (22%; P = 0.006) or placebo (29.4%; P < 0.001) groups. However, there was no difference among the groups concerning postoperative pain scores and length of postanaesthesia care unit stay. CONCLUSION: In paediatric patients undergoing strabismus surgery intranasal dexmedetomidine 2 mug kg premedication decreases the incidence of emergence delirium and PONV, and improves parents' satisfaction compared with oral midazolam. TRIAL REGISTRATION: ClinicalTrials.gov (identifier: NCT01895023).
32976205	11	26	dexmedetomidine	Chemical	MESH:D020927
32976205	39	48	midazolam	Chemical	MESH:D008874
32976205	74	92	emergence delirium	Disease	MESH:D000071257
32976205	116	126	strabismus	Disease	MESH:D013285
32976205	179	194	Dexmedetomidine	Chemical	MESH:D020927
32976205	324	339	dexmedetomidine	Chemical	MESH:D020927
32976205	374	383	midazolam	Chemical	MESH:D008874
32976205	389	407	emergence delirium	Disease	MESH:D000071257
32976205	504	519	dexmedetomidine	Chemical	MESH:D020927
32976205	524	542	emergence delirium	Disease	MESH:D000071257
32976205	561	568	patient	Species	9606
32976205	784	792	PATIENTS	Species	9606
32976205	820	828	patients	Species	9606
32976205	856	866	strabismus	Disease	MESH:D013285
32976205	917	925	Patients	Species	9606
32976205	1004	1019	dexmedetomidine	Chemical	MESH:D020927
32976205	1034	1049	dexmedetomidine	Chemical	MESH:D020927
32976205	1063	1072	midazolam	Chemical	MESH:D008874
32976205	1088	1097	midazolam	Chemical	MESH:D008874
32976205	1206	1224	emergence delirium	Disease	MESH:D000071257
32976205	1264	1282	Emergence Delirium	Disease	MESH:D000071257
32976205	1361	1370	emergence	Disease	MESH:D004630
32976205	1377	1395	postoperative pain	Disease	MESH:D010149
32976205	1473	1505	postoperative nausea or vomiting	Disease	MESH:D020250
32976205	1507	1511	PONV	Disease	MESH:D020250
32976205	1566	1584	emergence delirium	Disease	MESH:D000071257
32976205	1598	1606	patients	Species	9606
32976205	1613	1628	dexmedetomidine	Chemical	MESH:D020927
32976205	1651	1659	patients	Species	9606
32976205	1666	1675	midazolam	Chemical	MESH:D008874
32976205	1881	1885	PONV	Disease	MESH:D020250
32976205	1903	1918	dexmedetomidine	Chemical	MESH:D020927
32976205	1949	1958	midazolam	Chemical	MESH:D008874
32976205	2075	2093	postoperative pain	Disease	MESH:D010149
32976205	2173	2181	patients	Species	9606
32976205	2193	2203	strabismus	Disease	MESH:D013285
32976205	2223	2238	dexmedetomidine	Chemical	MESH:D020927
32976205	2289	2307	emergence delirium	Disease	MESH:D000071257
32976205	2312	2316	PONV	Disease	MESH:D020250
32976205	2372	2381	midazolam	Chemical	MESH:D008874
32976205	Negative_Correlation	MESH:D020927	MESH:D013285
32976205	Negative_Correlation	MESH:D020927	MESH:D000071257
32976205	Comparison	MESH:D008874	MESH:D020927
32976205	Negative_Correlation	MESH:D008874	MESH:D013285
32976205	Negative_Correlation	MESH:D020927	MESH:D020250
32976205	Negative_Correlation	MESH:D008874	MESH:D000071257

